Publicaciones científicas en Inglés. 2015

Tamargo J, Caballero R, Delpón E.
The Renin-Angiotensin System and Bone.
Clinic Rev Bone Miner Metab. 2015;13:125-148.

Tamargo J, Castellano JM, Fuster V.
The Fuster-CNIC-Ferrer Cardiovascular Polypill: a polypill for secondary cardiovascular prevention.

Int J Cardiol. 2015 Dec;201 Suppl 1:S15-22. doi: 10.1016/S0167-5273(15)31028-7.

Niessner A, Tamargo J, Morais J, Koller L, Wassmann S, Husted SE, Torp-Pedersen C, Kjeldsen K, Lewis BS, Drexel H, Kaski JC, Atar D, Storey RF, Lip GY, Verheugt FW, Agewall S.
Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on Thrombosis. Eur
Heart J. 2015 Dec 24. pii: ehv676. [Epub ahead of print] Review.

Authors/Task Force Members , Habib G , Lancellotti P , Antunes MJ , Bongiorni MG , Casalta JP , Del Zotti F , Dulgheru R , El Khoury G , Erba PA , Iung B , Miro JM , Mulder BJ , Plonska-Gosciniak E , Price S , Roos-Hesselink J , Snygg-Martin U , Thuny F , Tornos Mas P , Vilacosta I , Zamorano JL.
2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM).

Eur Heart J. 2015 ov 21;36(44):3075-128. doi: 10.1093/eurheartj/ehv319.

Camm AJ, Manolis A, Ambrosio G, Daly C, Komajda M, Lopez de Sa E, Lopez-Sendon JL, Mugelli A, Muggli F, Tamargo J.
Unresolved issues in the management of chronic stable angina.

Int J Cardiol. 2015 Dec 15;201:200-7. doi: 10.1016/j.ijcard.2015.08.045.

Rosano GM, Lewis B, Agewall S, Wassmann S, Vitale C, Schmidt H, Drexel H, Patak A, Torp-Pedersen C, Kjeldsen KP, Tamargo J.
Gender differences in the effect of cardiovascular drugs: a position document of the Working Group on Pharmacology and Drug Therapy of the ESC.
Eur Heart J . 2015 Oct 21;36(40):2677-80.

Daimi H, Lozano-Velasco E, Haj Khelil A, Chibani JB, Barana A, Amorós I, González de la Fuente M, Caballero R, Aranega A, Franco D.
Regulation of SCN5A by microRNAs: miR-219 modulates SCN5A transcript expression and the effects of flecainide intoxication in mice.
Heart Rhythm. 2015 Jun;12(6):1333-42. doi: 10.1016/j.hrthm.2015.02.018.

Tamargo J, Le Heuzey JY, Mabo P.
Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide.
Eur J Clin Pharmacol. 2015 May;71(5):549-67.

Tamargo J, Caballero R, Delpón E.
Cancer chemotherapy and cardiac arrhythmias: a review.
Drug Saf. 2015 Feb;38(2):129-52.

Tamargo J, Duarte J, Ruilope LM.
New Antihypertensive Drugs Under Development.
Curr Med Chem. 2015;22(3):305-42